A phase 2 study of idelalisib plus rituximab in treatment-naïve older patients with chronic lymphocytic leukemia von O'Brien, Susan M., Lamanna, Nicole, Kipps, Thomas J., Flinn, Ian, Zelenetz, Andrew D., Burger, Jan A., Keating, Michael, Mitra, Siddhartha, Holes, Leanne, Yu, Albert S., Johnson, David M., Miller, Langdon L., Kim, Yeonhee, Dansey, Roger D., Dubowy, Ronald L., Coutre, Steven E.

Volltext

The impact of complex karyotype on the overall survival of patients with relapsed chronic lymphocytic leukemia treated with idelalisib plus rituximab von Kreuzer, Karl-Anton, Furman, Richard R., Stilgenbauer, Stephan, Dubowy, Ronald L., Kim, Yeonhee, Munugalavadla, Veerendra, Lilienweiss, Esther, Reinhardt, Hans Christian, Cramer, Paula, Eichhorst, Barbara, Hillmen, Peter, O’Brien, Susan M., Pettitt, Andrew R., Hallek, Michael

Volltext

Pathological assessment of gastrointestinal biopsies from patients with idelalisib-associated diarrhea and colitis von Yeung, Cecilia CS, Hockenbery, David M, Westerhoff, Maria, Coutre, Steven E, Sedlak, Ruth H, Dubowy, Ronald L, Munugalavadla, Veerendra, Taylor, Kerry, Bosch, Francesc

Volltext

Phase I Clinical and Pharmacologic Study of Weekly Cisplatin and Irinotecan Combined with Amifostine for Refractory Solid Tumors von SOUID, Abdul-Kader, DUBOWY, Ronald L, BLANEY, Susan M, HERSHON, Linda, SULLIVAN, Jim, MCLEOD, Wendy D, BERNSTEIN, Mark L

Volltext

Activation of Carboplatin by Carbonate von Di Pasqua, Anthony J, Goodisman, Jerry, Kerwood, Deborah J, Toms, Bonnie B, Dubowy, Ronald L, Dabrowiak, James C

Volltext

Role of Carbonate in the Cytotoxicity of Carboplatin von Di Pasqua, Anthony J, Goodisman, Jerry, Kerwood, Deborah J, Toms, Bonnie B, Dubowy, Ronald L, Dabrowiak, James C

Volltext

Anakinra (AKR) prophylaxis (ppx) in patients (pts) with relapsed/refractory multiple myeloma (RRMM) receiving orvacabtagene autoleucel (orva-cel) von Costa, Luciano J., Mailankody, Sham, Shaughnessy, Paul, Hari, Parameswaran, Kaufman, Jonathan L., Larson, Sarah Marie, Dingli, David, Lee, Kelvin, Conte, Kristin, DeVries, Todd, Piasecki, Julia, Li, Meng, Dubowy, Ronald L., Htut, Myo

Volltext

Teaching teachers about childhood cancer: the effects of a web-based training program von Dubowy, Ronald L, Rieger, Brian P, Songer, Nan S, Kleinmann, Ava E, Lewandowski, Lawrence J, Rogers, Cynthia L, Silber, Jennifer M

Volltext

Outcome of Patients with Complex Karyotype in a Phase 3 Randomized Study of Idelalisib Plus Rituximab for Relapsed Chronic Lymphocytic Leukemia von Kreuzer, Karl-Anton, Furman, Richard R., Stilgenbauer, Stephan, Dubowy, Ronald L., Kim, Yeonhee, Munugalavadla, Veerendra, Lilienweiss, Esther, Reinhardt, Hans Christian, Pettitt, Andrew R., Hallek, Michael

Volltext

Phase 3 trial of momelotinib (MMB) vs ruxolitinib (RUX) in JAK inhibitor (JAKi) naive patients with myelofibrosis (MF) von Mesa, Ruben A., Kiladjian, Jean-Jacques, Catalano, John V., Devos, Timothy, Egyed, Miklos, Hellman, Andrzei, McLornan, Donal, Shimoda, Kazuya, Winton, Elliott F., Deng, Wei, Dubowy, Ronald L., Maltzman, Julia D., Cervantes, Francisco, Gotlib, Jason R.

Volltext

Whole-Exome Sequencing Revealed No Recurrent Mutations within the PI3K Pathway in Relapsed Chronic Lymphocytic Leukemia Patients Progressing Under Idelalisib Treatment von Ghia, Paolo, Ljungström, Viktor, Tausch, Eugen, Agathangelidis, Andreas, Scheffold, Annika, Scarfo, Lydia, Jebaraj, Billy Michael Chelliah, Owen, Carolyn J., Barrientos, Jacqueline C., Zapatka, Marc, Munugalavadla, Veerendra, Degenhardt, Jeremiah D., Kim, Yeonhee, Dubowy, Ronald L., Dreiling, Lyndah K., Rosenquist, Richard, Stilgenbauer, Stephan

Volltext

A Phase 2 Study of Idelalisib Monotherapy in Previously Untreated Patients ≥65 Years with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) von Zelenetz, Andrew D., Lamanna, Nicole, Kipps, Thomas J., Coutre, Steven E., O’Brien, Susan, Aiello, Maria, Cho, Yoonjin, Dubowy, Ronald L., Flinn, Ian W.

Volltext

Update on a Phase 2 Study of Idelalisib in Combination with Rituximab in Treatment-Naïve Patients ≥65 Years with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (S... von O’Brien, Susan, Lamanna, Nicole, Kipps, Thomas J., Flinn, Ian W., Zelenetz, Andrew D., Burger, Jan A., Holes, Leanne M., Cho, Yoonjin, Dubowy, Ronald L., Coutre, Steven E.

Volltext

Idelalisib, a Selective Inhibitor Of PI3Kδ, In Combination With Bendamustine, Fludarabine Or Chlorambucil In Patients With Relapsed Or Refractory (R/R) Chronic Lymphocytic Leukemia... von De Vos, Sven, Furman, Richard R., Barrientos, Jacqueline C., Wagner-Johnston, Nina D., Flinn, Ian, Sharman, Jeff P., Boyd, Thomas, Leonard, John P., Dansey, Roger, Kim, Yeonhee, Holes, Leanne M., Dubowy, Ronald L., Coutre, Steven E.

Volltext

A phase III, randomized, controlled study evaluating the efficacy and safety of idelalisib (GS-1101) in combination with ofatumumab for previously treated chronic lymphocytic leuke... von Flinn, Ian, Kimby, Eva, Cotter, Finbarr E., Giles, Francis J., Janssens, Ann, Pulczynski, Elisa Jacobsen, Ysebeart, Loic, Pluta, Andrzej, Garcia Marco, Jose Antonio, Taylor, Kerry, Owen, Carolyn, Johnson, David Michael, Aiello, Maria, Dansey, Roger D., Dubowy, Ronald L., Jones, Jeffrey Alan

Volltext

Clinical Activity Of Idelalisib (GS-1101), a Selective Inhibitor Of PI3Kδ, In Phase 1 and 2 Trials In Chronic Lymphocytic Leukemia (CLL): Effect Of Del(17p)/TP53 Mutation, Del(11q)... von Coutre, Steven E., Leonard, John P., Barrientos, Jacqueline C., De Vos, Sven, Flinn, Ian, Furman, Richard R., Brown, Jennifer R, Wagner-Johnston, Nina, Benson, Don M., Schreeder, Marshall T., Sharman, Jeff P., Boyd, Thomas, Spurgeon, Stephen, Zelenetz, Andrew D., Lamanna, Nicole, Kipps, Thomas J., Kahl, Brad S., Bello, Celeste M., Burger, Jan A., Rai, Kanti R., Dansey, Roger, Kim, Yeonhee, Holes, Leanne M., Lazarov, Mirella, Dubowy, Ronald L., O'Brien, Susan M.

Volltext

Phase I study of intravenous PI3K inhibitor BAY 80-6946: Activity in patients (pts) with advanced solid tumors and non-Hodgkin lymphoma treated in MTD expansion cohorts von Lotze, Michael T., Appleman, Leonard Joseph, Ramanathan, Ramesh K., Tolcher, Anthony W., Beeram, Muralidhar, Papadopoulos, Kyriakos P., Rasco, Drew Warren, Weiss, Glen J., Mountz, James M, Toledo, Frederico G.S., Alvarez, Rene J, Oborski, Matthew J, Rajagopalan, Prabhu, Jeffers, Michael, Roth, Diane, Dubowy, Ronald L., Patnaik, Amita

Volltext

A Pediatric Phase 1 Trial and Pharmacokinetic Study of Ispinesib: A Children's Oncology Group Phase I Consortium Study von Souid, Abdul-Kader, Dubowy, Ronald L., Ingle, Ashish M., Conlan, Maureen G., Sun, Junfeng, Blaney, Susan M., Adamson, Peter C.

Volltext

Inhibition of human malignant neuroblastoma cell DNA synthesis by lipoxygenase metabolites of arachidonic acid von WERNER, E. J, WALENGA, R. W, DUBOWY, R. L, BOONE, S, STUART, M. J

Volltext

Determination of the cytoprotective agent WR-2721 (Amifostine, Ethyol®) and its metabolites in human blood using monobromobimane fluorescent labeling and high-performance liquid ch... von SOUID, A.-K, NEWTON, G. L, DUBOWY, R. L, FAHEY, R. C, BERNSTEIN, M. L

Volltext